{"title":"标准化持续性和慢性危重病:定义差异对患病率和死亡率的影响","authors":"Toshinobu Nakai, Yuki Kotani, Yoshiro Hayashi","doi":"10.1186/s13054-025-05335-5","DOIUrl":null,"url":null,"abstract":"<p>Standardization of terminology and definitions is essential for scientific communication. Without such standardization, some studies may use different terms to express similar conditions, and other studies may use the same term with different definitions. Such diversities in medical language creates inconsistencies in scientific reporting, thereby hindering us from properly understanding the condition.</p><p>In this regard, persistent critical illness (PerCI) and chronic critical illness (CCI) are two terms used to describe prolonged critical conditions beyond the acute phase [1, 2]. However, the absence of standardized definitions leads to substantial variability in their clinical implications. Recently, <i>Critical Care</i> published a systematic scoping review highlighting the heterogeneity in definitions, epidemiology, and outcomes of PerCI and CCI [3]. We commend the authors for their comprehensive analysis, which synthesizes data obtained from numerous studies, performs a meta-analysis on specific patient populations (e.g., overall populations, sepsis, trauma, and COVID-19), and offers valuable recommendations for future research.</p><p>To further expand on the insights provided by Ohbe et al., we conducted an exploratory analysis to illustrate how different PerCI/CCI definitions impact reported prevalence and in-hospital mortality. From the 99 studies included in Ohbe et al.’s scoping review [3], we selected those explicitly reporting PerCI/CCI definitions, prevalence, and in-hospital mortality. We then created a scatter plot, where each dot represents a study, with PerCI/CCI prevalence on the x-axis and in-hospital mortality on the y-axis (Fig. 1), using Excel version 16.94. Dots were color-coded according to the PerCI/CCI definition applied in each study. This visualization underscores the substantial variability in prevalence and mortality based on the chosen definition.</p><figure><figcaption><b data-test=\"figure-caption-text\">Fig. 1</b></figcaption><picture><source srcset=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-025-05335-5/MediaObjects/13054_2025_5335_Fig1_HTML.png?as=webp\" type=\"image/webp\"/><img alt=\"figure 1\" aria-describedby=\"Fig1\" height=\"400\" loading=\"lazy\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-025-05335-5/MediaObjects/13054_2025_5335_Fig1_HTML.png\" width=\"685\"/></picture><p>Prevalence and hospital mortality according to the different persistent/chronic critical illness definitions</p><span>Full size image</span><svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-chevron-right-small\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></figure><p>Studies defining PerCI/CCI as “ICU stay ≥ 14 days with persistent organ dysfunction” (orange) reported higher prevalence compared to other definitions. This trend may be attributed to the study populations, which predominantly consisted of septic patients. Given that sepsis is strongly associated with organ dysfunction and prolonged ICU stays [4], it is reasonable to expect a higher prevalence of PerCI/CCI. Conversely, studies employing the definition “ICU stay ≥ 10 days” (yellow) primarily included non-specific ICU patients (53.3%), resulting in a lower prevalence.</p><p>Studies using the definitions “ICU stay ≥ 8 days and one of six eligible clinical conditions\" (gray) reported lower prevalence but higher in-hospital mortality. Among these six clinical conditions, prolonged mechanical ventilation was the most common [5], likely selecting a smaller but more critically ill patient group with worse outcomes.</p><p>Meanwhile, studies defining PerCI/CCI as “mechanical ventilation ≥ 14 days or tracheostomy” (blue) showed lower prevalence and lower in-hospital mortality. These study populations were predominantly composed of trauma patients, suggesting that the lower mortality rate reflects the relatively favorable prognosis of trauma patients, who typically have fewer comorbidities compared to septic patients.</p><p>Our exploratory analysis highlights the pressing need for a standardized PerCI/CCI definition. Establishing a uniform definition is essential for accurate identification, risk stratification, targeted interventions, and shared decision-making. We urge multidisciplinary discussions to optimize long-term care strategies for critically ill patients.</p><p>Further information on the original manuscript is available from the corresponding authors upon reasonable request.</p><dl><dt style=\"min-width:50px;\"><dfn>PerCI:</dfn></dt><dd>\n<p>Persistent critical illness</p>\n</dd><dt style=\"min-width:50px;\"><dfn>CCI:</dfn></dt><dd>\n<p>Chronic critical illness</p>\n</dd><dt style=\"min-width:50px;\"><dfn>ICU:</dfn></dt><dd>\n<p>Intensive care unit</p>\n</dd></dl><ol data-track-component=\"outbound reference\" data-track-context=\"references section\"><li data-counter=\"1.\"><p>Lamas D. Chronic critical illness. N Engl J Med. 2014;370:175–7.</p><p>Article CAS PubMed Google Scholar </p></li><li data-counter=\"2.\"><p>Darvall JN, Boonstra T, Norman J, Murphy D, Bailey M, Iwashyna TJ, et al. Persistent critical illness: baseline characteristics, intensive care course, and cause of death. Crit Care Resusc. 2019;21:110–8.</p><p>PubMed Google Scholar </p></li><li data-counter=\"3.\"><p>Ohbe H, Satoh K, Totoki T, Tanikawa A, Shirasaki K, Kuribayashi Y, et al. Definitions, epidemiology, and outcomes of persistent/chronic critical illness: a scoping review for translation to clinical practice. Crit Care. 2024;28:435.</p><p>Article PubMed PubMed Central Google Scholar </p></li><li data-counter=\"4.\"><p>Mira JC, Gentile LF, Mathias BJ, Efron PA, Brakenridge SC, Mohr AM, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;45:253–62.</p><p>Article PubMed PubMed Central Google Scholar </p></li><li data-counter=\"5.\"><p>Kahn JM, Le T, Angus DC, Cox CE, Hough CL, White DB, et al. The epidemiology of chronic critical illness in the United States. Crit Care Med. 2015;43:282–7.</p><p>Article PubMed PubMed Central Google Scholar </p></li></ol><p>Download references<svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></p><p>Not applicable.</p><p>Not applicable.</p><h3>Authors and Affiliations</h3><ol><li><p>Department of Intensive Care Medicine, Kameda Medical Center, 929 Higashi-Cho, Kamogawa, Chiba, 296-8602, Japan</p><p>Toshinobu Nakai, Yuki Kotani & Yoshiro Hayashi</p></li></ol><span>Authors</span><ol><li><span>Toshinobu Nakai</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Yuki Kotani</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Yoshiro Hayashi</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li></ol><h3>Contributions</h3><p>TN, YK, and YH wrote and approved the final manuscript.</p><h3>Corresponding author</h3><p>Correspondence to Yuki Kotani.</p><h3>Ethics approval and consent to participate</h3>\n<p>Not applicable.</p>\n<h3>Consent for publication</h3>\n<p>Not applicable.</p>\n<h3>Competing interests</h3>\n<p>The authors declare no competing interests.</p><h3>Publisher's Note</h3><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p><p><b>Open Access</b> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.</p>\n<p>Reprints and permissions</p><img alt=\"Check for updates. Verify currency and authenticity via CrossMark\" height=\"81\" loading=\"lazy\" src=\"data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>\" width=\"57\"/><h3>Cite this article</h3><p>Nakai, T., Kotani, Y. & Hayashi, Y. Standardizing persistent and chronic critical illness: impact of definitions variability on prevalence and mortality. <i>Crit Care</i> <b>29</b>, 102 (2025). https://doi.org/10.1186/s13054-025-05335-5</p><p>Download citation<svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></p><ul data-test=\"publication-history\"><li><p>Received<span>: </span><span><time datetime=\"2025-02-16\">16 February 2025</time></span></p></li><li><p>Accepted<span>: </span><span><time datetime=\"2025-02-22\">22 February 2025</time></span></p></li><li><p>Published<span>: </span><span><time datetime=\"2025-03-07\">07 March 2025</time></span></p></li><li><p>DOI</abbr><span>: </span><span>https://doi.org/10.1186/s13054-025-05335-5</span></p></li></ul><h3>Share this article</h3><p>Anyone you share the following link with will be able to read this content:</p><button data-track=\"click\" data-track-action=\"get shareable link\" data-track-external=\"\" data-track-label=\"button\" type=\"button\">Get shareable link</button><p>Sorry, a shareable link is not currently available for this article.</p><p data-track=\"click\" data-track-action=\"select share url\" data-track-label=\"button\"></p><button data-track=\"click\" data-track-action=\"copy share url\" data-track-external=\"\" data-track-label=\"button\" type=\"button\">Copy to clipboard</button><p> Provided by the Springer Nature SharedIt content-sharing initiative </p>","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"12 1","pages":""},"PeriodicalIF":8.8000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Standardizing persistent and chronic critical illness: impact of definitions variability on prevalence and mortality\",\"authors\":\"Toshinobu Nakai, Yuki Kotani, Yoshiro Hayashi\",\"doi\":\"10.1186/s13054-025-05335-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Standardization of terminology and definitions is essential for scientific communication. Without such standardization, some studies may use different terms to express similar conditions, and other studies may use the same term with different definitions. Such diversities in medical language creates inconsistencies in scientific reporting, thereby hindering us from properly understanding the condition.</p><p>In this regard, persistent critical illness (PerCI) and chronic critical illness (CCI) are two terms used to describe prolonged critical conditions beyond the acute phase [1, 2]. However, the absence of standardized definitions leads to substantial variability in their clinical implications. Recently, <i>Critical Care</i> published a systematic scoping review highlighting the heterogeneity in definitions, epidemiology, and outcomes of PerCI and CCI [3]. We commend the authors for their comprehensive analysis, which synthesizes data obtained from numerous studies, performs a meta-analysis on specific patient populations (e.g., overall populations, sepsis, trauma, and COVID-19), and offers valuable recommendations for future research.</p><p>To further expand on the insights provided by Ohbe et al., we conducted an exploratory analysis to illustrate how different PerCI/CCI definitions impact reported prevalence and in-hospital mortality. From the 99 studies included in Ohbe et al.’s scoping review [3], we selected those explicitly reporting PerCI/CCI definitions, prevalence, and in-hospital mortality. We then created a scatter plot, where each dot represents a study, with PerCI/CCI prevalence on the x-axis and in-hospital mortality on the y-axis (Fig. 1), using Excel version 16.94. Dots were color-coded according to the PerCI/CCI definition applied in each study. This visualization underscores the substantial variability in prevalence and mortality based on the chosen definition.</p><figure><figcaption><b data-test=\\\"figure-caption-text\\\">Fig. 1</b></figcaption><picture><source srcset=\\\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-025-05335-5/MediaObjects/13054_2025_5335_Fig1_HTML.png?as=webp\\\" type=\\\"image/webp\\\"/><img alt=\\\"figure 1\\\" aria-describedby=\\\"Fig1\\\" height=\\\"400\\\" loading=\\\"lazy\\\" src=\\\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-025-05335-5/MediaObjects/13054_2025_5335_Fig1_HTML.png\\\" width=\\\"685\\\"/></picture><p>Prevalence and hospital mortality according to the different persistent/chronic critical illness definitions</p><span>Full size image</span><svg aria-hidden=\\\"true\\\" focusable=\\\"false\\\" height=\\\"16\\\" role=\\\"img\\\" width=\\\"16\\\"><use xlink:href=\\\"#icon-eds-i-chevron-right-small\\\" xmlns:xlink=\\\"http://www.w3.org/1999/xlink\\\"></use></svg></figure><p>Studies defining PerCI/CCI as “ICU stay ≥ 14 days with persistent organ dysfunction” (orange) reported higher prevalence compared to other definitions. This trend may be attributed to the study populations, which predominantly consisted of septic patients. Given that sepsis is strongly associated with organ dysfunction and prolonged ICU stays [4], it is reasonable to expect a higher prevalence of PerCI/CCI. Conversely, studies employing the definition “ICU stay ≥ 10 days” (yellow) primarily included non-specific ICU patients (53.3%), resulting in a lower prevalence.</p><p>Studies using the definitions “ICU stay ≥ 8 days and one of six eligible clinical conditions\\\" (gray) reported lower prevalence but higher in-hospital mortality. Among these six clinical conditions, prolonged mechanical ventilation was the most common [5], likely selecting a smaller but more critically ill patient group with worse outcomes.</p><p>Meanwhile, studies defining PerCI/CCI as “mechanical ventilation ≥ 14 days or tracheostomy” (blue) showed lower prevalence and lower in-hospital mortality. These study populations were predominantly composed of trauma patients, suggesting that the lower mortality rate reflects the relatively favorable prognosis of trauma patients, who typically have fewer comorbidities compared to septic patients.</p><p>Our exploratory analysis highlights the pressing need for a standardized PerCI/CCI definition. Establishing a uniform definition is essential for accurate identification, risk stratification, targeted interventions, and shared decision-making. We urge multidisciplinary discussions to optimize long-term care strategies for critically ill patients.</p><p>Further information on the original manuscript is available from the corresponding authors upon reasonable request.</p><dl><dt style=\\\"min-width:50px;\\\"><dfn>PerCI:</dfn></dt><dd>\\n<p>Persistent critical illness</p>\\n</dd><dt style=\\\"min-width:50px;\\\"><dfn>CCI:</dfn></dt><dd>\\n<p>Chronic critical illness</p>\\n</dd><dt style=\\\"min-width:50px;\\\"><dfn>ICU:</dfn></dt><dd>\\n<p>Intensive care unit</p>\\n</dd></dl><ol data-track-component=\\\"outbound reference\\\" data-track-context=\\\"references section\\\"><li data-counter=\\\"1.\\\"><p>Lamas D. Chronic critical illness. N Engl J Med. 2014;370:175–7.</p><p>Article CAS PubMed Google Scholar </p></li><li data-counter=\\\"2.\\\"><p>Darvall JN, Boonstra T, Norman J, Murphy D, Bailey M, Iwashyna TJ, et al. Persistent critical illness: baseline characteristics, intensive care course, and cause of death. Crit Care Resusc. 2019;21:110–8.</p><p>PubMed Google Scholar </p></li><li data-counter=\\\"3.\\\"><p>Ohbe H, Satoh K, Totoki T, Tanikawa A, Shirasaki K, Kuribayashi Y, et al. Definitions, epidemiology, and outcomes of persistent/chronic critical illness: a scoping review for translation to clinical practice. Crit Care. 2024;28:435.</p><p>Article PubMed PubMed Central Google Scholar </p></li><li data-counter=\\\"4.\\\"><p>Mira JC, Gentile LF, Mathias BJ, Efron PA, Brakenridge SC, Mohr AM, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;45:253–62.</p><p>Article PubMed PubMed Central Google Scholar </p></li><li data-counter=\\\"5.\\\"><p>Kahn JM, Le T, Angus DC, Cox CE, Hough CL, White DB, et al. The epidemiology of chronic critical illness in the United States. Crit Care Med. 2015;43:282–7.</p><p>Article PubMed PubMed Central Google Scholar </p></li></ol><p>Download references<svg aria-hidden=\\\"true\\\" focusable=\\\"false\\\" height=\\\"16\\\" role=\\\"img\\\" width=\\\"16\\\"><use xlink:href=\\\"#icon-eds-i-download-medium\\\" xmlns:xlink=\\\"http://www.w3.org/1999/xlink\\\"></use></svg></p><p>Not applicable.</p><p>Not applicable.</p><h3>Authors and Affiliations</h3><ol><li><p>Department of Intensive Care Medicine, Kameda Medical Center, 929 Higashi-Cho, Kamogawa, Chiba, 296-8602, Japan</p><p>Toshinobu Nakai, Yuki Kotani & Yoshiro Hayashi</p></li></ol><span>Authors</span><ol><li><span>Toshinobu Nakai</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Yuki Kotani</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Yoshiro Hayashi</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li></ol><h3>Contributions</h3><p>TN, YK, and YH wrote and approved the final manuscript.</p><h3>Corresponding author</h3><p>Correspondence to Yuki Kotani.</p><h3>Ethics approval and consent to participate</h3>\\n<p>Not applicable.</p>\\n<h3>Consent for publication</h3>\\n<p>Not applicable.</p>\\n<h3>Competing interests</h3>\\n<p>The authors declare no competing interests.</p><h3>Publisher's Note</h3><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p><p><b>Open Access</b> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.</p>\\n<p>Reprints and permissions</p><img alt=\\\"Check for updates. Verify currency and authenticity via CrossMark\\\" height=\\\"81\\\" loading=\\\"lazy\\\" src=\\\"data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>\\\" width=\\\"57\\\"/><h3>Cite this article</h3><p>Nakai, T., Kotani, Y. & Hayashi, Y. Standardizing persistent and chronic critical illness: impact of definitions variability on prevalence and mortality. <i>Crit Care</i> <b>29</b>, 102 (2025). https://doi.org/10.1186/s13054-025-05335-5</p><p>Download citation<svg aria-hidden=\\\"true\\\" focusable=\\\"false\\\" height=\\\"16\\\" role=\\\"img\\\" width=\\\"16\\\"><use xlink:href=\\\"#icon-eds-i-download-medium\\\" xmlns:xlink=\\\"http://www.w3.org/1999/xlink\\\"></use></svg></p><ul data-test=\\\"publication-history\\\"><li><p>Received<span>: </span><span><time datetime=\\\"2025-02-16\\\">16 February 2025</time></span></p></li><li><p>Accepted<span>: </span><span><time datetime=\\\"2025-02-22\\\">22 February 2025</time></span></p></li><li><p>Published<span>: </span><span><time datetime=\\\"2025-03-07\\\">07 March 2025</time></span></p></li><li><p>DOI</abbr><span>: </span><span>https://doi.org/10.1186/s13054-025-05335-5</span></p></li></ul><h3>Share this article</h3><p>Anyone you share the following link with will be able to read this content:</p><button data-track=\\\"click\\\" data-track-action=\\\"get shareable link\\\" data-track-external=\\\"\\\" data-track-label=\\\"button\\\" type=\\\"button\\\">Get shareable link</button><p>Sorry, a shareable link is not currently available for this article.</p><p data-track=\\\"click\\\" data-track-action=\\\"select share url\\\" data-track-label=\\\"button\\\"></p><button data-track=\\\"click\\\" data-track-action=\\\"copy share url\\\" data-track-external=\\\"\\\" data-track-label=\\\"button\\\" type=\\\"button\\\">Copy to clipboard</button><p> Provided by the Springer Nature SharedIt content-sharing initiative </p>\",\"PeriodicalId\":10811,\"journal\":{\"name\":\"Critical Care\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":8.8000,\"publicationDate\":\"2025-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13054-025-05335-5\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13054-025-05335-5","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
摘要
术语和定义的标准化对科学传播至关重要。如果没有这样的标准化,一些研究可能会使用不同的术语来表达类似的情况,而另一些研究可能会使用不同定义的相同术语。医学语言的这种多样性造成了科学报告的不一致,从而阻碍了我们正确理解这种情况。在这方面,持续性危重疾病(persistent critical disease, PerCI)和慢性危重疾病(chronic critical disease, CCI)是两个术语,用于描述急性期之后的延长危重状态[1,2]。然而,由于缺乏标准化的定义,导致其临床意义存在很大差异。最近,《Critical Care》发表了一篇系统的范围综述,强调了ci和CCI在定义、流行病学和结果方面的异质性。我们赞扬作者的综合分析,该分析综合了从众多研究中获得的数据,对特定患者群体(如总体人群、败血症、创伤和COVID-19)进行了荟萃分析,并为未来的研究提供了有价值的建议。为了进一步扩展Ohbe等人提供的见解,我们进行了一项探索性分析,以说明不同的PerCI/CCI定义如何影响报告的患病率和住院死亡率。从Ohbe等人的范围综述bbb中纳入的99项研究中,我们选择了那些明确报告了ci /CCI定义、患病率和住院死亡率的研究。然后,我们创建了一个散点图,其中每个点代表一项研究,x轴为PerCI/CCI患病率,y轴为院内死亡率(图1),使用Excel版本16.94。根据每个研究中应用的PerCI/CCI定义对圆点进行颜色编码。该可视化图强调了基于所选定义的患病率和死亡率的实质性变化。根据不同的持续/慢性危重疾病定义的患病率和住院死亡率研究将ci /CCI定义为“ICU住院≥14天伴有持续器官功能障碍”(橙色)的研究报告的患病率高于其他定义。这一趋势可能归因于研究人群中主要由脓毒症患者组成。考虑到脓毒症与器官功能障碍和延长ICU住院时间密切相关,我们有理由期待更高的PerCI/CCI患病率。相反,采用“ICU住院≥10天”(黄色)定义的研究主要包括非特异性ICU患者(53.3%),因此患病率较低。使用“ICU住院≥8天,6个符合条件的临床条件之一”(灰色)定义的研究报告患病率较低,但住院死亡率较高。在这六种临床情况中,延长机械通气是最常见的[5],可能选择了一个更小但更严重的患者组,结果更差。与此同时,将ci /CCI定义为“机械通气≥14天或气管切开术”(蓝色)的研究显示出更低的患病率和更低的住院死亡率。这些研究人群主要由创伤患者组成,表明较低的死亡率反映了创伤患者相对较好的预后,与脓毒症患者相比,创伤患者通常具有较少的合并症。我们的探索性分析强调了对标准化的PerCI/CCI定义的迫切需要。建立统一的定义对于准确识别、风险分层、有针对性的干预和共同决策至关重要。我们敦促进行多学科讨论,以优化危重患者的长期护理策略。有关原稿的进一步信息,可根据合理要求从通讯作者处获得。i:持续性重症cci:慢性重症icu:重症监护病房中华医学杂志,2014;37(3):557 - 557。[文献]学者Darvall JN, Boonstra T, Norman J, Murphy D, Bailey M, Iwashyna TJ,等。持续性危重疾病:基线特征、重症监护过程和死亡原因。危重监护复苏[j]; 2019;21:11 - 8。PubMed bbb学者Ohbe H, Satoh K, Totoki T, Tanikawa A, Shirasaki K, Kuribayashi Y,等。定义,流行病学,和持续性/慢性危重疾病的结果:翻译到临床实践的范围审查。危重症护理。2024;28:435。学者Mira JC, Gentile LF, Mathias BJ, Efron PA, Brakenridge SC, Mohr AM等。脓毒症病理生理、慢性危重疾病、持续性炎症-免疫抑制和分解代谢综合征。危重症护理,2017;45:253-62。文章PubMed PubMed Central bbb学者Kahn JM, Le T, Angus DC, Cox CE, Hough CL, White DB,等。美国慢性危重疾病的流行病学。危重症护理,2015;43:282-7。文章PubMed PubMed Central b谷歌学者下载参考文献不适用。 不适用。作者与单位:日本千叶县神川市东町929号神田医疗中心重症医学科296-8602中井信、小谷由纪等;Yoshiro HayashiAuthorsToshinobu NakaiView作者出版物您也可以在PubMed b谷歌ScholarYuki KotaniView作者出版物您也可以在PubMed谷歌ScholarYoshiro HayashiView作者出版物您也可以在PubMed谷歌ScholarContributionsTN, YK和YH撰写并批准最终稿件。通讯作者小谷由纪通讯。对参与者的伦理批准和同意不适用。发表同意不适用。利益竞争作者声明没有利益竞争。出版商声明:对于已出版的地图和机构关系中的管辖权要求,普林格·自然保持中立。开放获取本文遵循知识共享署名4.0国际许可协议,该协议允许以任何媒介或格式使用、共享、改编、分发和复制,只要您适当地注明原作者和来源,提供知识共享许可协议的链接,并注明是否进行了更改。本文中的图像或其他第三方材料包含在文章的知识共享许可协议中,除非在材料的署名中另有说明。如果材料未包含在文章的知识共享许可中,并且您的预期用途不被法律法规允许或超过允许的用途,您将需要直接获得版权所有者的许可。要查看本许可协议的副本,请访问http://creativecommons.org/licenses/by/4.0/.Reprints并访问permissionsCite本文akai, T., Kotani, Y. &;标准化持续性和慢性危重疾病:定义变异对患病率和死亡率的影响。危重症护理29,102(2025)。https://doi.org/10.1186/s13054-025-05335-5Download citation:收稿日期:2025年2月16日接受日期:2025年2月22日发布日期:2025年3月7日doi: https://doi.org/10.1186/s13054-025-05335-5Share本文任何您与之分享以下链接的人都可以阅读此内容:获取可共享链接对不起,本文目前没有可共享链接。复制到剪贴板由施普林格自然共享内容倡议提供
Standardizing persistent and chronic critical illness: impact of definitions variability on prevalence and mortality
Standardization of terminology and definitions is essential for scientific communication. Without such standardization, some studies may use different terms to express similar conditions, and other studies may use the same term with different definitions. Such diversities in medical language creates inconsistencies in scientific reporting, thereby hindering us from properly understanding the condition.
In this regard, persistent critical illness (PerCI) and chronic critical illness (CCI) are two terms used to describe prolonged critical conditions beyond the acute phase [1, 2]. However, the absence of standardized definitions leads to substantial variability in their clinical implications. Recently, Critical Care published a systematic scoping review highlighting the heterogeneity in definitions, epidemiology, and outcomes of PerCI and CCI [3]. We commend the authors for their comprehensive analysis, which synthesizes data obtained from numerous studies, performs a meta-analysis on specific patient populations (e.g., overall populations, sepsis, trauma, and COVID-19), and offers valuable recommendations for future research.
To further expand on the insights provided by Ohbe et al., we conducted an exploratory analysis to illustrate how different PerCI/CCI definitions impact reported prevalence and in-hospital mortality. From the 99 studies included in Ohbe et al.’s scoping review [3], we selected those explicitly reporting PerCI/CCI definitions, prevalence, and in-hospital mortality. We then created a scatter plot, where each dot represents a study, with PerCI/CCI prevalence on the x-axis and in-hospital mortality on the y-axis (Fig. 1), using Excel version 16.94. Dots were color-coded according to the PerCI/CCI definition applied in each study. This visualization underscores the substantial variability in prevalence and mortality based on the chosen definition.
Fig. 1
Prevalence and hospital mortality according to the different persistent/chronic critical illness definitions
Full size image
Studies defining PerCI/CCI as “ICU stay ≥ 14 days with persistent organ dysfunction” (orange) reported higher prevalence compared to other definitions. This trend may be attributed to the study populations, which predominantly consisted of septic patients. Given that sepsis is strongly associated with organ dysfunction and prolonged ICU stays [4], it is reasonable to expect a higher prevalence of PerCI/CCI. Conversely, studies employing the definition “ICU stay ≥ 10 days” (yellow) primarily included non-specific ICU patients (53.3%), resulting in a lower prevalence.
Studies using the definitions “ICU stay ≥ 8 days and one of six eligible clinical conditions" (gray) reported lower prevalence but higher in-hospital mortality. Among these six clinical conditions, prolonged mechanical ventilation was the most common [5], likely selecting a smaller but more critically ill patient group with worse outcomes.
Meanwhile, studies defining PerCI/CCI as “mechanical ventilation ≥ 14 days or tracheostomy” (blue) showed lower prevalence and lower in-hospital mortality. These study populations were predominantly composed of trauma patients, suggesting that the lower mortality rate reflects the relatively favorable prognosis of trauma patients, who typically have fewer comorbidities compared to septic patients.
Our exploratory analysis highlights the pressing need for a standardized PerCI/CCI definition. Establishing a uniform definition is essential for accurate identification, risk stratification, targeted interventions, and shared decision-making. We urge multidisciplinary discussions to optimize long-term care strategies for critically ill patients.
Further information on the original manuscript is available from the corresponding authors upon reasonable request.
PerCI:
Persistent critical illness
CCI:
Chronic critical illness
ICU:
Intensive care unit
Lamas D. Chronic critical illness. N Engl J Med. 2014;370:175–7.
Article CAS PubMed Google Scholar
Darvall JN, Boonstra T, Norman J, Murphy D, Bailey M, Iwashyna TJ, et al. Persistent critical illness: baseline characteristics, intensive care course, and cause of death. Crit Care Resusc. 2019;21:110–8.
PubMed Google Scholar
Ohbe H, Satoh K, Totoki T, Tanikawa A, Shirasaki K, Kuribayashi Y, et al. Definitions, epidemiology, and outcomes of persistent/chronic critical illness: a scoping review for translation to clinical practice. Crit Care. 2024;28:435.
Article PubMed PubMed Central Google Scholar
Mira JC, Gentile LF, Mathias BJ, Efron PA, Brakenridge SC, Mohr AM, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;45:253–62.
Article PubMed PubMed Central Google Scholar
Kahn JM, Le T, Angus DC, Cox CE, Hough CL, White DB, et al. The epidemiology of chronic critical illness in the United States. Crit Care Med. 2015;43:282–7.
Article PubMed PubMed Central Google Scholar
Download references
Not applicable.
Not applicable.
Authors and Affiliations
Department of Intensive Care Medicine, Kameda Medical Center, 929 Higashi-Cho, Kamogawa, Chiba, 296-8602, Japan
Toshinobu Nakai, Yuki Kotani & Yoshiro Hayashi
Authors
Toshinobu NakaiView author publications
You can also search for this author in PubMedGoogle Scholar
Yuki KotaniView author publications
You can also search for this author in PubMedGoogle Scholar
Yoshiro HayashiView author publications
You can also search for this author in PubMedGoogle Scholar
Contributions
TN, YK, and YH wrote and approved the final manuscript.
Corresponding author
Correspondence to Yuki Kotani.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Reprints and permissions
Cite this article
Nakai, T., Kotani, Y. & Hayashi, Y. Standardizing persistent and chronic critical illness: impact of definitions variability on prevalence and mortality. Crit Care29, 102 (2025). https://doi.org/10.1186/s13054-025-05335-5
Download citation
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13054-025-05335-5
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
期刊介绍:
Critical Care is an esteemed international medical journal that undergoes a rigorous peer-review process to maintain its high quality standards. Its primary objective is to enhance the healthcare services offered to critically ill patients. To achieve this, the journal focuses on gathering, exchanging, disseminating, and endorsing evidence-based information that is highly relevant to intensivists. By doing so, Critical Care seeks to provide a thorough and inclusive examination of the intensive care field.